• レポートコード:MRC2211A039 • 出版社/出版日:Persistence Market Research / 2022年8月 • レポート形態:英文、PDF、300ページ • 納品方法:Eメール • 産業分類:医療 |
Single User | ¥725,200 (USD4,900) | ▷ お問い合わせ |
Site Licence | ¥1,124,800 (USD7,600) | ▷ お問い合わせ |
Enterprisewide | ¥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートは、神経外科の世界市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症の危機分析、需要分析・予測、製品別(ニューロインターベンションデバイス、神経内視鏡、脳神経外科用ドリル、ラジオサージェリーシステム、硬膜代替物)分析、エンドユーザー別(病院、外来手術センター、神経専門施設)分析、地域別(北米、中南米、ヨーロッパ、南アジア、東アジア、オセアニア、中東/アフリカ)分析、仮定、調査手法などを整理しております。本書では、Stryker Corp.、B. Braun Melsungen AG、Medtronic plc、DePuy Synthes、Boston Scientific、Terumo Corporation、KARL STORZ GmbH&Co KG、Integra LifeSciences、Penumbra Inc、Adeor Medical AGなどの企業情報が含まれています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・新型コロナウイルス感染症の危機分析 ・需要分析・予測 ・世界の神経外科市場規模:製品別 - ニューロインターベンションデバイスの市場規模 - 神経内視鏡の市場規模 - 脳神経外科用ドリルの市場規模 - ラジオサージェリーシステムの市場規模 - 硬膜代替物の市場規模 ・世界の神経外科市場規模:エンドユーザー別 - 病院における市場規模 - 外来手術センターにおける市場規模 - 神経専門施設における市場規模 ・世界の神経外科市場規模:地域別 - 北米の神経外科市場規模 - 中南米の神経外科市場規模 - ヨーロッパの神経外科市場規模 - 南アジアの神経外科市場規模 - 東アジアの神経外科市場規模 - オセアニアの神経外科市場規模 - 中東/アフリカの神経外科市場規模 ・仮定 ・調査手法 |
Neurosurgery Market: Scope of Report
The latest publication by Persistence Market Research on the global neurosurgery market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2022-2032.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for neurosurgery market products and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the neurosurgery market insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the neurosurgery market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the neurosurgery market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the neurosurgery market offers information divided into three important segments – product, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Product
Neuro Interventional Devices
Neurovascular Embolization Devices
Embolization Coils
Liquid Embolic Systems
Flow Diversion Stents
Aneurysm Clips
Neurovascular Coiling Assist Devices
Coiling Assist Stents
Coiling Assist Balloons
Neurovascular Thrombectomy Devices
Stent Retrievers
Aspiration Retrievers
Microguidewires
Microcatheters
Support Catheters
Intracranial Stents
Neuroendoscopes
Flexible Neuroendoscopes
Rigid Neuroendoscopes
Neurosurgical Drills
Pneumatic Neurosurgical Drills
Electrical Neurosurgical Drills
Radiosurgery Systems
Linear Accelerator Radiosurgery Systems
Gamma Knife Radiosurgery Systems
Dura Substitutes
Biological Dura Substitutes
Synthetic Dura Substitutes
Neurosurgical Ablation Devices
MRI Guided Focused Ultrasound Systems
MRI Guided Laser Therapy Systems
MRI Guided RF Ablation Systems
Neurosurgery Instruments
Tissue Retractors
Forceps
Head Frames
Cervical Plating systems
Perforators
End User
Hospitals
Ambulatory Surgical Centers
Specialized Neurological Institutes
Region
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa
Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for neurosurgery over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the neurosurgery market avail themselves of the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the neurosurgery market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the neurosurgery market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions & Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Key Disease Epidemiology
4.2. Product Adoption / Usage Analysis
4.3. Product USPs / Features
4.4. Key Promotional Strategies, By Manufacturers
4.5. Porter’s Analysis
4.6. PESTLE Analysis
4.7. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Market GDP and Growth Outlook
5.1.2. Global Assistive Devices Market Overview
5.1.3. Medical Device Industry Overview
5.2. Forecast Factors – Relevance & Impact
5.2.1. GDP Growth Forecast
5.2.2. Ageing Population
5.2.3. Growing Prevalence of Neurologic Diseases
5.2.4. Growing Healthcare Expenditure
5.2.5. Shift Towards Minimally Invasive Procedures
5.2.6. Growing Research Efforts
5.2.7. Cost Impact
5.2.8. Entries Of New Start-Up Companies In The Market
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. Revenue By Product
6.1.2. Revenue By End User
6.1.3. Revenue by Country
6.2. 2021 Market Scenario
7. Global Neurosurgery Market Demand (in Value or Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022–2032
7.1. Historical Market Value (US$ Mn) Analysis, 2017–2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product, 2017–2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022–2032
8.3.1. Neuro Interventional Devices
8.3.1.1. Neurovascular Embolization Devices
8.3.1.1.1. Embolization Coils
8.3.1.1.2. Liquid Embolic Systems
8.3.1.1.3. Flow Diversion Stents
8.3.1.1.4. Aneurysm Clips
8.3.1.2. Neurovascular Coiling Assist Devices
8.3.1.2.1. Coiling Assist Stents
8.3.1.2.2. Coiling Assist Balloons
8.3.1.3. Neurovascular Thrombectomy Devices
8.3.1.3.1. Stent Retrievers
8.3.1.3.2. Aspiration Retrievers
8.3.1.4. Microguidewires
8.3.1.5. Microcatheters
8.3.1.6. Support Catheters
8.3.1.7. Intracranial Stents
8.3.2. Neuroendoscopes
8.3.2.1. Flexible Neuroendoscopes
8.3.2.2. Rigid Neuroendoscopes
8.3.3. Neurosurgical Drills
8.3.3.1. Pneumatic Neurosurgical Drills
8.3.3.2. Electrical Neurosurgical Drills
8.3.4. Radiosurgery Systems
8.3.4.1. Linear Accelerator Radiosurgery Systems
8.3.4.2. Gamma Knife Radiosurgery Systems
8.3.5. Dura Substitutes
8.3.5.1. Biological Dura Substitutes
8.3.5.2. Synthetic Dura Substitutes
8.3.6. Neurosurgical Ablation Devices
8.3.6.1. MRI Guided Focused Ultrasound Systems
8.3.6.2. MRI Guided Laser Therapy Systems
8.3.6.3. MRI Guided RF Ablation Systems
8.3.7. Neurosurgery Instruments
8.3.7.1. Tissue Retractors
8.3.7.2. Forceps
8.3.7.3. Head Frames
8.3.7.4. Cervical Plating systems
8.3.7.5. Perforators
8.4. Market Attractiveness Analysis By Product
9. Global Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Specialized Neurological Institutes
9.4. Market Attractiveness Analysis By End User
10. Global Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Product
11.3.3. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Product
11.4.3. By End User
11.5. Market Trends
11.6. Key Market Participants – Intensity Mapping
11.7. Drivers and Restraints – Impact Analysis
11.8. Country Level Analysis & Forecast
11.8.1. U.S. Neurosurgery Market
11.8.1.1. Introduction
11.8.1.2. Market Analysis and Forecast by Market Taxonomy
11.8.1.2.1. By Product
11.8.1.2.2. By End User
11.8.2. Canada Neurosurgery Market
11.8.2.1. Introduction
11.8.2.2. Market Analysis and Forecast by Market Taxonomy
11.8.2.2.1. By Product
11.8.2.2.2. By End User
12. Latin America Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Argentina
12.3.1.3. Mexico
12.3.1.4. Rest of Latin America
12.3.2. By Product
12.3.3. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By End User
12.5. Market Trends
12.6. Key Market Participants – Intensity Mapping
12.7. Drivers and Restraints – Impact Analysis
12.8. Country Level Analysis & Forecast
12.8.1. Brazil Neurosurgery Market
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast by Market Taxonomy
12.8.1.2.1. By Product
12.8.1.2.2. By End User
12.8.2. Mexico Neurosurgery Market
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast by Market Taxonomy
12.8.2.2.1. By Product
12.8.2.2.2. By End User
12.8.3. Argentina Neurosurgery Market
12.8.3.1. Introduction
12.8.3.2. Market Analysis and Forecast by Market Taxonomy
12.8.3.2.1. By Product
12.8.3.2.2. By End User
13. Europe Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. France
13.3.1.3. Italy
13.3.1.4. Spain
13.3.1.5. UK
13.3.1.6. BENELUX
13.3.1.7. Russia
13.3.1.8. Nordic Countries
13.3.1.9. Rest of Europe
13.3.2. By Product
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By End User
13.5. Market Trends
13.6. Key Market Participants – Intensity Mapping
13.7. Drivers and Restraints – Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. Germany Neurosurgery Market
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By End User
13.8.2. Italy Neurosurgery Market
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By End User
13.8.3. France Neurosurgery Market
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast by Market Taxonomy
13.8.3.2.1. By Product
13.8.3.2.2. By End User
13.8.3.2.3.
13.8.4. Spain Neurosurgery Market
13.8.4.1. Introduction
13.8.4.2. Market Analysis and Forecast by Market Taxonomy
13.8.4.2.1. By Product
13.8.4.2.2. By End User
13.8.5. U.K. Neurosurgery Market
13.8.5.1. Introduction
13.8.5.2. Market Analysis and Forecast by Market Taxonomy
13.8.5.2.1. By Product
13.8.5.2.2. By End User
13.8.6. Benelux Union Neurosurgery Market
13.8.6.1. Introduction
13.8.6.2. Market Analysis and Forecast by Market Taxonomy
13.8.6.2.1. By Product
13.8.6.2.2. By End User
13.8.7. Nordic Countries Neurosurgery Market
13.8.7.1. Introduction
13.8.7.2. Market Analysis and Forecast by Market Taxonomy
13.8.7.2.1. By Product
13.8.7.2.2. By End User
13.8.8. Russia Neurosurgery Market
13.8.8.1. Introduction
13.8.8.2. Market Analysis and Forecast by Market Taxonomy
13.8.8.2.1. By Product
13.8.8.2.2. By End User
14. South Asia and Pacific Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Indonesia
14.3.1.3. Malaysia
14.3.1.4. Thailand
14.3.1.5. Rest of South Asia
14.3.2. By Product
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By End User
14.5. Market Trends
14.6. Key Market Participants – Intensity Mapping
14.7. Drivers and Restraints – Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. India Neurosurgery Market
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By End User
14.8.2. Indonesia Neurosurgery Market
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By End User
14.8.3. Malaysia Neurosurgery Market
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By End User
14.8.4. Thailand Neurosurgery Market
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast by Market Taxonomy
14.8.4.2.1. By Product
14.8.4.2.2. By End User
15. East Asia Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By End User
15.5. Market Trends
15.6. Key Market Participants – Intensity Mapping
15.7. Drivers and Restraints – Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. China Neurosurgery Market
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By End User
15.8.2. Japan Neurosurgery Market
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By End User
15.8.3. South Korea Neurosurgery Market
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By End User
16. Oceania Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Product
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By End User
16.5. Market Trends
16.6. Key Market Participants – Intensity Mapping
16.7. Drivers and Restraints – Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. Australia Neurosurgery Market
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By End User
16.8.2. New Zealand Neurosurgery Market
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By End User
17. Middle East and Africa Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Turkey
17.3.1.3. Israel
17.3.1.4. Northern Africa
17.3.1.5. South Africa
17.3.1.6. Rest of Middle East and Africa
17.3.2. By Product
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By End User
17.5. Market Trends
17.6. Key Market Participants – Intensity Mapping
17.7. Drivers and Restraints – Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. GCC Countries Neurosurgery Market
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By End User
17.8.2. Turkey Neurosurgery Market
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By End User
17.8.3. North Africa Neurosurgery Market
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By End User
17.8.4. South Africa Neurosurgery Market
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By End User
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. Stryker Corp.
19.3.1.1. .Overview
19.3.1.2. Product Portfolio
19.3.1.3. Key Financials
19.3.1.4. SWOT Analysis
19.3.1.5. Key Developments
19.3.1.6. Sales Footprint
19.3.1.7. Strategy Overview
19.3.1.7.1. Marketing Strategy
19.3.1.7.2. Product Strategy
19.3.1.7.3. Channel Strategy
19.3.2. B. Braun Melsungen AG
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Key Financials
19.3.2.4. SWOT Analysis
19.3.2.5. Key Developments
19.3.2.6. Sales Footprint
19.3.2.7. Strategy Overview
19.3.2.7.1. Marketing Strategy
19.3.2.7.2. Product Strategy
19.3.2.7.3. Channel Strategy
19.3.3. Medtronic plc
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Key Financials
19.3.3.4. SWOT Analysis
19.3.3.5. Key Developments
19.3.3.6. Sales Footprint
19.3.3.7. Strategy Overview
19.3.3.7.1. Marketing Strategy
19.3.3.7.2. Product Strategy
19.3.3.7.3. Channel Strategy
19.3.4. DePuy Synthes
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Key Financials
19.3.4.4. SWOT Analysis
19.3.4.5. Key Developments
19.3.4.6. Sales Footprint
19.3.4.7. Strategy Overview
19.3.4.7.1. Marketing Strategy
19.3.4.7.2. Product Strategy
19.3.4.7.3. Channel Strategy
19.3.5. Boston Scientific
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Key Financials
19.3.5.4. SWOT Analysis
19.3.5.5. Key Developments
19.3.5.6. Sales Footprint
19.3.5.7. Strategy Overview
19.3.5.7.1. Marketing Strategy
19.3.5.7.2. Product Strategy
19.3.5.7.3. Channel Strategy
19.3.6. Terumo Corporation
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Key Financials
19.3.6.4. SWOT Analysis
19.3.6.5. Key Developments
19.3.6.6. Sales Footprint
19.3.6.7. Strategy Overview
19.3.6.7.1. Marketing Strategy
19.3.6.7.2. Product Strategy
19.3.6.7.3. Channel Strategy
19.3.7. KARL STORZ GmbH & Co KG
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Key Financials
19.3.7.4. SWOT Analysis
19.3.7.5. Key Developments
19.3.7.6. Sales Footprint
19.3.7.7. Strategy Overview
19.3.7.7.1. Marketing Strategy
19.3.7.7.2. Product Strategy
19.3.7.7.3. Channel Strategy
19.3.8. Integra LifeSciences
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Key Financials
19.3.8.4. SWOT Analysis
19.3.8.5. Key Developments
19.3.8.6. Sales Footprint
19.3.8.7. Strategy Overview
19.3.8.7.1. Marketing Strategy
19.3.8.7.2. Product Strategy
19.3.8.7.3. Channel Strategy
19.3.9. Penumbra Inc
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Key Financials
19.3.9.4. SWOT Analysis
19.3.9.5. Key Developments
19.3.9.6. Sales Footprint
19.3.9.7. Strategy Overview
19.3.9.7.1. Marketing Strategy
19.3.9.7.2. Product Strategy
19.3.9.7.3. Channel Strategy
19.3.10. Adeor Medical AG
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Key Financials
19.3.10.4. SWOT Analysis
19.3.10.5. Key Developments
19.3.10.6. Sales Footprint
19.3.10.7. Strategy Overview
19.3.10.7.1. Marketing Strategy
19.3.10.7.2. Product Strategy
19.3.10.7.3. Channel Strategy
19.3.11. Elekta
19.3.11.1. Overview
19.3.11.2. Product Portfolio
19.3.11.3. Key Financials
19.3.11.4. SWOT Analysis
19.3.11.5. Key Developments
19.3.11.6. Sales Footprint
19.3.11.7. Strategy Overview
19.3.11.7.1. Marketing Strategy
19.3.11.7.2. Product Strategy
19.3.11.7.3. Channel Strategy
19.3.12. Clarus Medical
19.3.12.1. Overview
19.3.12.2. Product Portfolio
19.3.12.3. Key Financials
19.3.12.4. SWOT Analysis
19.3.12.5. Key Developments
19.3.12.6. Sales Footprint
19.3.12.7. Strategy Overview
19.3.12.7.1. Marketing Strategy
19.3.12.7.2. Product Strategy
19.3.12.7.3. Channel Strategy
19.3.13. MACHIDA ENDOSCOPE CO., LTD.
19.3.13.1. Overview
19.3.13.2. Product Portfolio
19.3.13.3. Key Financials
19.3.13.4. SWOT Analysis
19.3.13.5. Key Developments
19.3.13.6. Sales Footprint
19.3.13.7. Strategy Overview
19.3.13.7.1. Marketing Strategy
19.3.13.7.2. Product Strategy
19.3.13.7.3. Channel Strategy
20. Assumptions and Acronyms Used
21. Research Methodology
Table 01: Global Neurosurgery Market Size Volume (Units) Analysis 2017-2021 and Forecast, 2022-2032, By ProductTable 02: Global Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Product
Table 03: Global Neurosurgery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022-2032, By End User
Table 04: Global Neurosurgery Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Region
Table 05: North America Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 06: North America Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Product
Table 07: North America Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 08: Latin America Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 09: Latin America Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Product
Table 10: Latin America Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 11: Europe Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 12: Europe Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Product
Table 13: Europe Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 14: South Asia Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 15: South Asia Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Product
Table 16: South Asia Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 17: East Asia Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 18: East Asia Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Product
Table 19: East Asia Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 20: Oceania Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 21: Oceania Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Product
Table 22: Oceania Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 23: Middle East & Africa Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 24: Middle East & Africa Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Product
Table 25: Middle East & Africa Neurosurgery Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User